Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$0.53 - $0.93 $23,700 - $41,587
-44,718 Reduced 7.72%
534,621 $310,000
Q4 2023

Feb 09, 2024

SELL
$0.63 - $1.14 $48,135 - $87,101
-76,405 Reduced 11.65%
579,339 $480,000
Q3 2023

Nov 09, 2023

SELL
$1.12 - $1.88 $251,675 - $422,454
-224,710 Reduced 25.52%
655,744 $740,000
Q2 2023

Aug 11, 2023

SELL
$1.31 - $2.04 $758,986 - $1.18 Million
-579,379 Reduced 39.69%
880,454 $1.41 Million
Q1 2023

May 12, 2023

BUY
$1.45 - $2.95 $419,670 - $853,812
289,428 Added 24.73%
1,459,833 $2.22 Million
Q4 2022

Feb 08, 2023

BUY
$2.02 - $3.25 $1.98 Million - $3.19 Million
980,516 Added 516.36%
1,170,405 $2.81 Million
Q3 2022

Nov 10, 2022

BUY
$1.96 - $3.14 $368,262 - $589,971
187,889 Added 9394.45%
189,889 $389,000
Q2 2022

Aug 10, 2022

SELL
$1.3 - $2.64 $383,442 - $778,683
-294,956 Reduced 99.33%
2,000 $4,000
Q1 2022

May 16, 2022

SELL
$2.35 - $3.47 $1.61 Million - $2.37 Million
-683,022 Reduced 69.7%
296,956 $731,000
Q4 2021

Feb 14, 2022

BUY
$2.92 - $5.74 $2.51 Million - $4.93 Million
858,121 Added 704.2%
979,978 $3.16 Million
Q3 2021

Nov 15, 2021

BUY
$4.98 - $6.63 $590,618 - $786,304
118,598 Added 3639.09%
121,857 $640,000
Q2 2021

Aug 13, 2021

SELL
$2.56 - $5.49 $794,585 - $1.7 Million
-310,385 Reduced 98.96%
3,259 $18,000
Q1 2021

May 12, 2021

BUY
$2.69 - $5.25 $813,445 - $1.59 Million
302,396 Added 2688.44%
313,644 $853,000
Q4 2020

Feb 11, 2021

BUY
$3.17 - $4.49 $24,887 - $35,250
7,851 Added 231.12%
11,248 $36,000
Q3 2020

Nov 12, 2020

BUY
$2.98 - $5.2 $4,318 - $7,534
1,449 Added 74.38%
3,397 $14,000
Q2 2020

Jul 31, 2020

SELL
$2.29 - $4.24 $104,588 - $193,649
-45,672 Reduced 95.91%
1,948 $8,000
Q1 2020

May 01, 2020

SELL
$1.92 - $4.39 $109,848 - $251,165
-57,213 Reduced 54.58%
47,620 $117,000
Q4 2019

Feb 14, 2020

BUY
$2.41 - $4.4 $121,982 - $222,706
50,615 Added 93.35%
104,833 $426,000
Q3 2019

Nov 14, 2019

BUY
$2.17 - $3.14 $76,008 - $109,984
35,027 Added 182.52%
54,218 $140,000
Q2 2019

Aug 14, 2019

BUY
$2.53 - $3.04 $14,479 - $17,397
5,723 Added 42.49%
19,191 $58,000
Q1 2019

May 14, 2019

SELL
$2.51 - $3.73 $54,981 - $81,705
-21,905 Reduced 61.93%
13,468 $40,000
Q4 2018

Feb 14, 2019

BUY
$1.59 - $2.66 $21,261 - $35,569
13,372 Added 60.78%
35,373 $85,000
Q3 2018

Nov 14, 2018

BUY
$1.59 - $2.42 $14,615 - $22,244
9,192 Added 71.76%
22,001 $47,000
Q2 2018

Aug 14, 2018

SELL
$2.26 - $4.65 $281,614 - $579,427
-124,608 Reduced 90.68%
12,809 $29,000
Q1 2018

May 15, 2018

BUY
$3.51 - $6.04 $444,660 - $765,171
126,684 Added 1180.32%
137,417 $647,000
Q4 2017

Feb 14, 2018

BUY
$3.26 - $4.78 $24,388 - $35,759
7,481 Added 230.04%
10,733 $35,000
Q3 2017

Nov 14, 2017

SELL
$3.48 - $4.44 $20,204 - $25,778
-5,806 Reduced 64.1%
3,252 $14,000
Q2 2017

Aug 14, 2017

BUY
N/A
8,985 Added 12308.22%
9,058 $35,000
Q1 2017

Nov 14, 2017

BUY
N/A
73
73 $0

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.